# Cannabidiol Oil for Treatment-Resistant Major Depression

> **NCT07696871** · PHASE1,PHASE2 · RECRUITING · sponsor: **Universidade do Sul de Santa Catarina** · enrollment: 120 (estimated)

## Conditions studied

- Major Depressive Disorder (MDD)
- Treatment-resistant Depression (TRD)

## Interventions

- **DRUG:** Full-spectrum CBD oil 100 mg/mL
- **DRUG:** Placebo oil (MCT oil)

## Key facts

- **NCT ID:** NCT07696871
- **Lead sponsor:** Universidade do Sul de Santa Catarina
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-07-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07696871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07696871, "Cannabidiol Oil for Treatment-Resistant Major Depression". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07696871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*